Literature DB >> 1825941

Cytokine induction of neopterin production.

D C Henderson1, J Sheldon, P Riches, J R Hobbs.   

Abstract

The pteridine neopterin is a marker of immunological activation and has been shown to be a useful marker of graft-versus-host disease (GVHD) in bone marrow transplant patients. High levels of both neopterin and interferon-gamma (IFN-gamma) were produced in vitro during mixed lymphocyte responses, which may be considered to be a model of the primary events leading to GVHD. Neopterin was shown to be produced by monocytes in response to stimulation with IFN-gamma, but not other cytokines. However, the interleukins IL-1 alpha, IL-1 beta, IL-2, and tumour necrosis factor (TNF) alpha and beta, but not IL-6, stimulated neopterin production by unfractionated peripheral blood mononuclear cells (PBMC), and culture supernatants from PBMC stimulated with IL-1 alpha, IL-1 beta, IL-2 and IL-6, but not TNF-alpha or TNF-beta induced neopterin production following transfer to fresh monocyte cultures. It therefore appears that cytokines may generate neopterin by induction of IFN-gamma, by synergy with low levels of induced IFN-gamma, or by non-IFN-gamma-dependent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825941      PMCID: PMC1535323          DOI: 10.1111/j.1365-2249.1991.tb05664.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  9 in total

1.  Simultaneous determination of serum neopterin and C-reactive protein as markers of infection in heart-transplant recipients.

Authors:  I Myara; V Atger; C Cosson; R Guillemain; C Amrein; G Dreyfus; N Moatti
Journal:  Clin Chem       Date:  1989-06       Impact factor: 8.327

Review 2.  Neopterin as a marker for activated cell-mediated immunity: application in HIV infection.

Authors:  D Fuchs; A Hausen; G Reibnegger; E R Werner; M P Dierich; H Wachter
Journal:  Immunol Today       Date:  1988-05

3.  Purification of human monocytes/macrophages by adherence to cytodex microcarriers.

Authors:  L M Kumaratilake; A Ferrante
Journal:  J Immunol Methods       Date:  1988-09-13       Impact factor: 2.303

4.  Pteridines as a new marker to detect human T cells activated by allogeneic or modified self major histocompatibility complex (MHC) determinants.

Authors:  C Huber; D Fuchs; A Hausen; R Margreiter; G Reibnegger; M Spielberger; H Wachter
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

5.  Neopterin as a new biochemical marker in the clinical monitoring of bone marrow transplant recipients.

Authors:  D Niederwieser; C Huber; A Gratwohl; P Bannert; D Fuchs; A Hausen; G Reibnegger; B Speck; H Wachter
Journal:  Transplantation       Date:  1984-11       Impact factor: 4.939

6.  In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS).

Authors:  J Troppmair; K Nachbaur; M Herold; W Aulitzky; H Tilg; G Gastl; P Bieling; B Kotlan; R Flener; B Mull
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

7.  Hyperphenylalaninemia due to a deficiency of biopterin. A variant form of phenylketonuria.

Authors:  S Kaufman; S Berlow; G K Summer; S Milstien; J D Schulman; S Orloff; S Spielberg; S Pueschel
Journal:  N Engl J Med       Date:  1978-09-28       Impact factor: 91.245

Review 8.  The cytokine network.

Authors:  F R Balkwill; F Burke
Journal:  Immunol Today       Date:  1989-09

9.  Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.

Authors:  C Huber; J R Batchelor; D Fuchs; A Hausen; A Lang; D Niederwieser; G Reibnegger; P Swetly; J Troppmair; H Wachter
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

  9 in total
  7 in total

1.  Secretory IgA are elevated in both saliva and serum of patients with various types of primary glomerulonephritis.

Authors:  G Rostoker; H Terzidis; M Petit-Phar; D Meillet; P Lang; J M Dubert; G Lagrue; B Weil
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

2.  Immune system of cold-exposed and cold-adapted humans.

Authors:  L Janský; D Pospísilová; S Honzová; B Ulicný; P Srámek; V Zeman; J Kamínková
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

3.  Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features.

Authors:  P Aukrust; S S Frøland; F Müller
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

4.  Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha.

Authors:  B Hofmann; H Bass; P Nishanian; M Faisal; R A Figlin; G P Sarna; J L Fahey
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

5.  Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy.

Authors:  G Hahn; B Stuhlmüller; N Hain; J R Kalden; K Pfizenmaier; G R Burmester
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

6.  Relation between depression and circulating immune products in patients with advanced colorectal cancer.

Authors:  T G Allen-Mersh; C Glover; C Fordy; D C Henderson; M Davies
Journal:  J R Soc Med       Date:  1998-08       Impact factor: 5.344

7.  Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis.

Authors:  G Horneff; U Sack; J R Kalden; F Emmrich; G R Burmester
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.